Evidence map›Paper›PMID 33593729›Full record

ArticleBMJ open quality2021

Impact and costs of a hepatitis C virus screening programme for adults hospitalised at an academic medical centre.

Timothy J Whitman, Cindy D Noyes, Andrew J Hale, Devika Singh, Stephen G DeVoe, Allen B Repp, Kristen K Pierce, Louis B Polish, Beth D Kirkpatrick, Jean Dejace and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open quality, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Timothy J WhitmanDivision of Infectious Diseases, Department of Medicine, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA timothy.whitman@uvmhealth.org.
Cindy D NoyesDivision of Infectious Diseases, Department of Medicine, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.
Andrew J HaleDivision of Infectious Diseases, Department of Medicine, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.
Devika SinghDivision of Infectious Diseases, Department of Medicine, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.
Stephen G DeVoeDepartment of Medicine Quality Program, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.ORCID 0000-0002-1760-7752
Allen B ReppDepartment of Medicine Quality Program, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.ORCID 0000-0001-7513-532X
Kristen K PierceDivision of Infectious Diseases, Department of Medicine, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.
Louis B PolishDivision of Infectious Diseases, Department of Medicine, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.
Beth D KirkpatrickDivision of Infectious Diseases, Department of Medicine, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.
Jean DejaceDivision of Infectious Diseases, Department of Medicine, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.
Lindsay M SmithDivision of Infectious Diseases, Department of Medicine, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.
Tim LaheyDivision of Infectious Diseases, Department of Medicine, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.
Christopher D HustonDivision of Infectious Diseases, Department of Medicine, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.
Laura J CatoeDivision of Infectious Diseases, Department of Medicine, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.
Prateek GhatageDivision of Infectious Diseases, Department of Medicine, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.
Sean BullisDivision of Infectious Diseases, Department of Medicine, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.
W Kemper AlstonDivision of Infectious Diseases, Department of Medicine, The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, Vermont, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HepacivirusMass ScreeningAcademic Medical CentersAdultCost-Benefit AnalysisHumansclinical practice guidelinescost-effectivenessquality improvementstandards of care

Identifiers

PMID33593729
PMCPMC7888362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.